检索结果 - Kanwal Raghav
- Showing 1 - 20 results of 59
- Go to Next Page
-
1
-
2
-
3
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance) 由 Kanwal Raghav, Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz, Scott Kopetz
出版 2022Artigo -
4
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies 由 Joseph M. Unger, Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari, Michael J. Overman, Jonathan M. Loree, Kanwal Raghav
出版 2020Artigo -
5
-
6
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer 由 Giulia Siravegna, Andrea Sartore‐Bianchi, Rebecca J. Nagy, Kanwal Raghav, Justin I. Odegaard, Richard B. Lanman, Livio Trusolino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli
出版 2019Artigo -
7
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 由 Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav
出版 2019Artigo -
8
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... 由 Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman
出版 2016Artigo -
9
-
10
International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel 由 Satoshi Fujii, Anthony M. Magliocco, Jihun Kim, Wataru Okamoto, Jeong Eun Kim, Kentaro Sawada, Yoshiaki Nakamura, Scott Kopetz, Woong‐Yang Park, Katsuya Tsuchihara, Tae Won Kim, Kanwal Raghav, Takayuki Yoshino
出版 2020Artigo -
11
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers 由 Kanwal Raghav, Leonel F. Hernandez‐Aya, Xiudong Lei, Mariana Chávez‐MacGregor, Funda Meric‐Bernstam, Thomas A. Buchholz, Ayşegül A. Şahin, Kors Jan A., Gabriel N. Hortobágyi, Ana M. González-Angulo
出版 2011Artigo -
12
Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas 由 Kanwal Raghav, Aditya Shetty, Syed Mohammad Ali Kazmi, Nianxiang Zhang, Jeffrey S. Morris, Melissa W. Taggart, Keith F. Fournier, Richard E. Royal, Paul Mansfield, Cathy Eng, Robert A. Wolff, Michael J. Overman
出版 2013Artigo -
13
-
14
Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients 由 Suguru Yamashita, Eugene J. Koay, Guillaume Passot, Rachna T. Shroff, Kanwal Raghav, Claudius Conrad, Yun Shin Chun, Thomas A. Aloia, Randa Tao, Ahmed O. Kaseb, Milind Javle, Christopher H. Crane, Jean‐Nicolas Vauthey
出版 2016Artigo -
15
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia 由 Michael J. Overman, Renata Ferrarotto, Kanwal Raghav, Binsah George, Wei Qiao, Karime Kalil Machado, Leonard B. Saltz, Thibault Mazard, Jean‐Nicolas Vauthey, Paulo M. Hoff, Brian P. Hobbs, Evelyn Loyer, Scott Kopetz
出版 2017Artigo -
16
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer 由 Kanwal Raghav, John Paul Shen, Alexandre A. Jácome, Jennifer L. Guerra, Christopher P. Scally, Melissa W. Taggart, Wai Chin Foo, Aurelio Matamoros, Kenna Shaw, Keith F. Fournier, Michael J. Overman, Cathy Eng
出版 2020Artigo -
17
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers 由 Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad
出版 2019Artigo -
18
<i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma 由 Krittiya Korphaisarn, Van K. Morris, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Kanwal Raghav, Shanequa Manuel, Imad Shureiqi, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley R. Hamilton, Scott Kopetz, Arvind Dasari
出版 2017Artigo -
19
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with family gene alterations 由 Sarina A. Piha‐Paul, Chieh Tseng, Hai T. Tran, Aung Naing, Ecaterina E. Dumbrava, DD Karp, Jordi Rodón, Timothy A. Yap, Kanwal Raghav, Senthil Damodaran, Xiao‐Feng Le, P.T. Soliman, Jo Ann Lim, F. Meric-Bernstam
出版 2025Artigo -
20
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Revi... 由 Shen, Chan, Tannenbaum, Daniel, Horn, Robert, Rogers, Jane, Eng, Cathy, Zhou, Shouhao, Johnson, Benny, Kopetz, Scott, Morris, Van, Overman, Michael, Parseghian, Christine, Chang, George J., Lopez-Olivo, Maria A., Kanwal, Raghav, Ellis, Lee M., Dasari, Arvind
出版 2022Text
相关主题
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Biology
Cancer research
Gene
Gastroenterology
Genetics
Clinical trial
Cohort
Chemotherapy
KRAS
Breast cancer
Confidence interval
Surgery
Clinical endpoint
Immunotherapy
Adenocarcinoma
Cetuximab
Hazard ratio
Proportional hazards model
Bevacizumab
Biochemistry
Bioinformatics
Environmental health
Epidermal growth factor receptor
Oxaliplatin
Pathology